122 related articles for article (PubMed ID: 26142394)
1. Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease.
Wang JQ; Qin F; Zhu L
J Int Med Res; 2015 Oct; 43(5):629-38. PubMed ID: 26142394
[TBL] [Abstract][Full Text] [Related]
2. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease.
Mei C; Mao Z; Shen X; Wang W; Dai B; Tang B; Wu Y; Cao Y; Zhang S; Zhao H; Sun T
Nephrol Dial Transplant; 2005 Nov; 20(11):2368-75. PubMed ID: 16141466
[TBL] [Abstract][Full Text] [Related]
3. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
[TBL] [Abstract][Full Text] [Related]
4. Concomitant use of rapamycin and rosiglitazone delays the progression of polycystic kidney disease in Han:SPRD rats: a study of the mechanism of action.
Liu C; Li H; Gao X; Yang M; Yuan L; Fu L; Wang X; Mei C
Am J Physiol Renal Physiol; 2018 May; 314(5):F844-F854. PubMed ID: 26911848
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
Elberg D; Jayaraman S; Turman MA; Elberg G
Exp Cell Res; 2012 Aug; 318(13):1508-16. PubMed ID: 22504005
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of SPARC and its impact on proliferation and apoptosis in ADPKD cyst-lining epithelia.
Wang W; Mei C; Tang B; Zhao H; Xu C; Li Z; Shen X; Fu W; Dai B
Nephrol Dial Transplant; 2006 May; 21(5):1278-88. PubMed ID: 16421164
[TBL] [Abstract][Full Text] [Related]
7. Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease.
Su Z; Wang X; Gao X; Liu Y; Pan C; Hu H; Beyer RP; Shi M; Zhou J; Zhang J; Serra AL; Wüthrich RP; Mei C
J Intern Med; 2014 Nov; 276(5):470-85. PubMed ID: 24494798
[TBL] [Abstract][Full Text] [Related]
8. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease.
Nagao S; Yamaguchi T; Kusaka M; Maser RL; Takahashi H; Cowley BD; Grantham JJ
Kidney Int; 2003 Feb; 63(2):427-37. PubMed ID: 12631108
[TBL] [Abstract][Full Text] [Related]
9. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.
Cowley BD; Ricardo SD; Nagao S; Diamond JR
Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.
Liu C; Zhang Y; Yuan L; Fu L; Mei C
Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113
[TBL] [Abstract][Full Text] [Related]
12. Role of DNA-Dependent Protein Kinase in Mediating Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.
Chandra AN; Saravanabavan S; Rangan GK
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638853
[TBL] [Abstract][Full Text] [Related]
13. Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease.
Ecder T; Melnikov VY; Stanley M; Korular D; Lucia MS; Schrier RW; Edelstein CL
Kidney Int; 2002 Apr; 61(4):1220-30. PubMed ID: 11918728
[TBL] [Abstract][Full Text] [Related]
14. Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease.
Wahl PR; Le Hir M; Vogetseder A; Arcaro A; Starke A; Waeckerle-Men Y; Serra AL; Wuthrich RP
Nephrology (Carlton); 2007 Aug; 12(4):357-63. PubMed ID: 17635750
[TBL] [Abstract][Full Text] [Related]
15. CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/+) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD).
Gauer S; Holzmann Y; Kränzlin B; Hoffmann SC; Gretz N; Hauser IA; Goppelt-Struebe M; Geiger H; Obermüller N
J Histochem Cytochem; 2017 Dec; 65(12):743-755. PubMed ID: 29058957
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone inhibits cell proliferation by inducing G1 cell cycle arrest and apoptosis in ADPKD cyst-lining epithelia cells.
Liu Y; Dai B; Fu L; Jia J; Mei C
Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):523-30. PubMed ID: 20210794
[TBL] [Abstract][Full Text] [Related]
18. Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor.
Wallace DP; Quante MT; Reif GA; Nivens E; Ahmed F; Hempson SJ; Blanco G; Yamaguchi T
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1463-71. PubMed ID: 18753297
[TBL] [Abstract][Full Text] [Related]
19. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
Pan Y; Wang L; Dai JL
Breast Cancer Res; 2006; 8(6):R63. PubMed ID: 17078868
[TBL] [Abstract][Full Text] [Related]
20. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
Pey R; Bach J; Schieren G; Gretz N; Hafner M
In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
